Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports

Eli Lilly wants the UK to regularly raise NHS drug prices ​and phase out a multi-billion-pound rebate scheme if ‌it is to resume investment, its international businesses president Patrik Jonsson told the Financial Times.